Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study (Q84676387)
Jump to navigation
Jump to search
scientific article published on 24 February 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study |
scientific article published on 24 February 2011 |
Statements
Combined weekly topotecan and biweekly bevacizumab in women with platinum-resistant ovarian, peritoneal, or fallopian tube cancer: results of a phase 2 study (English)
Kathryn F McGonigle
Howard G Muntz
Jacqueline Vuky
Pamela J Paley
Dan S Veljovich
Benjamin E Greer
Heidi J Gray
Thomas W Malpass
24 February 2011